NCT02821793 Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer Status COMPLETED Phase N/A
NCT02762006 Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma Status COMPLETED Phase PHASE1
NCT02687139 Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma Status COMPLETED Phase NA
NCT02669914 MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors Status TERMINATED Phase PHASE2
NCT02511275 Nephrotoxicity Associated to Parenchymal Clamping During Partial Nephrectomy Using a Microdialysis Technique Status TERMINATED Phase NA
NCT02446795 Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial Status UNKNOWN Phase PHASE1/PHASE2
NCT02293980 A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02186925 A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. Status UNKNOWN Phase N/A
NCT02143492 Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC Status COMPLETED Phase N/A
NCT02141490 Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers Status COMPLETED Phase PHASE2
NCT02118337 A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT02060370 Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) Status COMPLETED Phase PHASE2
NCT02019693 A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer Status COMPLETED Phase PHASE2